Caitong International Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Caitong International Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$216	–	2605
2025 Q4	$216	Buy	+10	New	+$194	﹤0.01%	1607
2025 Q3	–	Sell	-543	Closed	-$4.81K	–	1948
2025 Q2	$4.81K	Buy	543 +80	+17%	+$703	﹤0.01%	1034
2025 Q1	$3.63K	Buy	+463	New	+$3.88K	﹤0.01%	1115

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Caitong International Asset Management's AVDL Position: Q1 2026 in Review

Caitong International Asset Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 10 shares — an estimated $216 sold.

Caitong International Asset Management first reported a position in AVDL in Q1 2025 and held it in 3 quarters. The position peaked at $4.81K in Q2 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Caitong International Asset Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Caitong International Asset Management sold 10 Avadel Pharmaceuticals shares in Q1 2026, an estimated $216.
Caitong International Asset Management first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 3 quarters.
Caitong International Asset Management's Avadel Pharmaceuticals position peaked at $4.81K in Q2 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.